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Abstract
The ability to create thick tissues is a major tissue
engineering challenge, requiring the development of a
suitable vascular supply. Current trends are seeing the
utilization of cells seeded into hybrid matrix/scaffold
systems to create in vitro vascular analogues. Approaches
that aim to create vasculature in vitro include the use of
biological extracellular matrices such as collagen hydrogels,
porous biodegradable polymeric scaffolds with macro- and
micro-lumens and micro-channels, co-culture of cells,
incorporation of growth factors, culture in dynamic
bioreactor environments, and combinations of these. Of
particular interest are those approaches that aim to create
bioengineered tissues in vitro that can be readily connected
to the host’s vasculature following implantation in order to
maintain cell viability.
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Introduction
The Thick Tissue Dilemma
As defined by the National Science Foundation, “Tissue
engineering is an interdisciplinary field that applies the
principles of engineering & the life sciences towards the
development of biological substitutes that restore,
maintain or improve tissue function.” (Skalak and Fox,
1988). A critical obstacle in tissue engineering is the
inability to maintain large masses of living cells upon
transfer from the in vitro culture conditions into the host
in vivo. In vivo most cells do not survive more than a few
hundred micrometers from the nearest capillary, due to
diffusion limitations (Frerich et al., 2001; Okano and
Matsuda, 1998; Sheridan et al., 2000). Capillaries, and
the vascular system, are required to supply essential
nutrients, including oxygen, remove waste products and
provide a biochemical communication “highway” (Cassell
et al., 2002; Eiselt et al., 1998; Nerem et al., 1998; Nguyen
and D’Amore, 2001; Nomi et al., 2002; Secomb and Pries,
2002). The circulatory system also contributes to the
control of temperature and pressure/perfusion through
vasoconstriction and vasodilation. The cardiovascular
system is also the earliest to develop in the embryo
(Auerbach and Auerbach, 2002; Nguyen and D’Amore,
2001) and the establishment and maintenance of a vascular
supply is an absolute requirement for the growth of both
normal and neoplastic tissues (Auerbach and Auerbach,
2002; Gridley, 2007). All tissues and organs (with the
exception of a minority of tissues such as cartilage) need
to be vascularised to be able to survive. Generating a
vascular supply to a thick tissue-engineered construct
remains a major challenge (Griffith et al., 2005; Grikscheit
and Vacanti, 2002): new blood vessels take days to develop
(Griffith and Naughton, 2002) which can lead, for
example, to predisposed ischaemia (Grounds, 2000). This
review will examine the process of vascularisation in vivo
and then explore the current methods of vascularising
bioengineered tissues and organs in vitro, which include
the use of microvascular cells and co-culture, and
biological and synthetic scaffolds, and explore a novel




Blood vessels are constructed by two processes,
angiogenesis, which is a morphogenic process involving
the sprouting of capillaries from pre-existing blood
vessels, and vasculogenesis, which is the in situ assembly
of capillaries from undifferentiated endothelial cells (EC).
Adult blood vessel formation may be a combination of
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the two (Cassell et al., 2002; Nguyen and D’Amore, 2001),
with the main target vessels for angiogenic stimuli being
the post-capillary venules and the small terminal venules.
The angiogenic process requires close interactions
between the extracellular matrix (ECM), cells and growth
factors to produce the required neovascularisation (Cassell
et al., 2002). There are six basic steps in angiogenesis:
vasodilation, basement membrane degradation, adherent
cell migration, formation of capillary lumen, synthesis of
basement membrane, and recruitment of pericytes and
vascular smooth muscle cells (Ahrendt et al., 1998;
Auerbach and Auerbach, 2002; Cassell et al., 2002; Downs,
2003; Egginton and Gerritsen, 2003; Folkman and
Haudenschild, 1980; Jain et al., 1997; Nomi et al., 2002;
Norrby, 1997; Vailhe et al., 2001).
The vasculogenesis process, like the angiogenesis
process, can be divided into six steps (Auerbach and
Auerbach, 2002; Nomi et al., 2002; Vailhe et al., 2001):
1.  The in situ differentiation of mesodermal cells into
angioblasts or hemangioblasts.
2.  EC are generated from precursor cells (angioblasts).
3.  EC form the vessel primordia and aggregates that
establish cell-to-cell contact but have no lumen.
4.  A nascent endothelial tube is formed, composed of
polarized EC.
5.  A primary vascular network is formed from an array
of nascent endothelial tubes.
6.  Pericytes and vascular smooth muscle cells are
recruited.
Figure 1 illustrates the key processes involved in tubule
formation and vascularisation of tissues in animals (Kannan
et al., 2005).
Once vessels are made, remodelling of the vascular
network occurs in response to the physiological demands
of the system. Remodelling of the vascular system involves
changes in lumen diameter and wall thickness to suit local
needs (Cassell et al., 2002) and can occur though
differentiation of the microvascular wall. Differentiation
of the microvascular wall can be related to (1) mechanical
factors, primarily the blood hydrostatic pressure that acts
on arterioles, and (2) metabolic factors related to the local
metabolic needs of tissues and reflected in peculiarities of
blood-tissue exchange vessels (capillaries and small
venules) (Slaaf et al., 1993). Intussusceptive microvascular
growth (IMG) is a concept of vascular morphogenesis and
remodelling that provides an alternative mechanism to
angiogenesis by endothelial sprouting. IMG refers to
partitioning of the perfused vessel lumen by the insertion
of interstitial (or intervascular) tissue structures or tissue
pillars. This is followed by growth of these structures
resulting in network expansion. IMG is also an important
mechanism of vascular network remodelling, defined as
rearrangement of the number and/or position of vascular
segments without significant network expansion (Jain et
al., 1997; Patan et al., 2001). IMG, however, has not been
observed so far in vascular analogue tissue engineering
research. So in order to identify an in vitro bioengineered
vascular analogue as functional, the created vasculature
has to be able to respond to both mechanical and metabolic
factors.
Blood vessel structure
The smallest microvessels are the capillaries with an inner
diameter of 4-10µm and a very thin wall of EC. The wall
thickness of microvessels can be as much as half the
luminal diameter. The boundary between arteriole and
capillary is marked by the disappearance of smooth muscle
cells (SMCs). The arterioles represent the major site of
Figure 1. The relationship between the various pathways to vessel development. Adapted from (Kannan, et al.,
2005).
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resistance to and regulation of local blood flow, with
arterioles varying in diameter from 10µm to 300µm, with
one or two layers of SMC helically arranged in the media,
with the inner lining consisting of endothelium (Slaaf et
al., 1993). However the transition from capillary to venule
is less well defined and occurs gradually. The immediate
post-capillary venules range in diameter from ~10-50µm
and initially lack SMC in their walls. They drain into
collecting venules, the diameter of which gradually
increases from ~50-300µm (Slaaf et al., 1993).
Large vessels are separate anatomical entities, whereas
microvessels are structurally and functionally part of the
tissue they supply for which the input for the
microcirculation of tissues is small arteries (Slaaf et al.,
1993). Immature endothelial-lined tubes that arise during
vasculogenesis and angiogenesis subsequently differentiate
into capillaries (after association with pericytes) or into
larger vessels such as arteries and veins (after forming a
media composed essentially of SMC).
Generation of vascular structures
Traditionally, research on vascularisation has relied on
animal models to observe and understand the process
(Norrby, 2006). Various models exist such as the
chorioallantoic membrane model (Borges et al., 2003b)
and the disc angiogenesis system (Kowalski et al., 1992),
as well as the analysis of the expression of various factors
associated with vascularisation after implantation of
scaffolds into animals such as mice (Vallien et al., 2000).
There has been some success in creating vascular
analogue scaffolds and precursor tissues in vivo. Implanted
cell-seeded constructs in animals have acted as living
bioreactors for cells within scaffolds, and models of
vascularisation in animals (Cassell et al., 2002; Koike et
al., 2004) have included adapted chorioallantoic membrane
(Borges et al., 2003a), porcine (Schultheiss et al., 2005),
mice (including nude mice) (Koike et al., 2004; Okano
and Matsuda, 1998; Sieminski et al., 2002), and
immunodeficient mouse (Nor et al., 2001) models.
Ischemia has also been shown to stimulate
vascularization. Circulating endothelial progenitor cells
(EPCs) have been mobilized endogenously in response to
tissue ischemia or exogenously by cytokine therapy and
seem to augment neovascularization of ischemic tissues
(Takahashi et al., 1999). Circulating mononuclear cells in
human peripheral blood have been shown to be
incorporated into foci of neovascularization, consistent
with postnatal vasculogenesis. In experiments, the
development of regional ischemia in both mice and rabbits
increases the frequency of circulating EPCs (Takahashi et
al., 1999).
Vascular Analogues In Vitro
Creation of vascular networks and mass transfer
considerations
The question of whether vascularisation can occur in vitro
without a blood supply is an important one. From a
functionality viewpoint, if we define a bioengineered vessel
as being viable when it can mimic everything a natural
vessel does in vivo, then we are currently disappointingly
short of that ideal target. Currently in biological and
synthetic scaffolds, in vitro formation of multi-branching
networks of cells (Kaihara et al., 2000; Wu et al., 2004),
lumens (Egginton and Gerritsen, 2003; Sieminski and
Gooch, 2004; Sieminski et al., 2004), contiguous vessel
walls (Black et al., 1998), and responsiveness to chemical
and biophysical signals (Lee et al., 2000), have been
observed. But nothing so far has been able to compare to
the effectiveness and quality of microvascular network
formation in vivo (Borges et al., 2003a; Patan et al., 2001).
This may be due in part to the complex combination of
biochemical signals in blood and the biophysical influences
that accompany blood flow (Lee and Schmid-Schonbein,
1995; Pries and Secomb, 2002). Unless we are able to
elucidate and simulate the complex biochemical cocktail
in blood, as well as the biophysical environment during
blood flow, we may well need a blood supply to create a
functional microvascular system.
Pre-capillary and vessel networks can occur in various
forms in vitro and on various substrates and materials
(Kannan et al., 2005; Moldovan and Ferrari, 2002; Vailhe
et al., 2001). Two regulatory pathways have been proposed
by which angiogenesis is thought to proceed. The
proliferative pathway depends on various cytokines and
other factors that both stimulate and inhibit the proliferation
of EC. The morphogenetic pathway depends on the
synthesis and assembly of fibrillar type 1 collagen, which
can be used as a template for EC migration and lumen
formation. EC interact with substrates of type 1 collagen
and form networks based on the establishment of traction
centres. These planar cellular networks, in some respects,
resemble developing vasculature in vivo (Sage and Vernon,
1994).
The use of microvascular EC (MVEC), the key cells
for vascularisation in the body, for angiogenesis in vitro
was demonstrated in 1980 (Folkman and Haudenschild,
1980) and subsequently by others (Bachetti and Morbidelli,
2000). Some groups have been able to reconstruct semi-
vascularised bioengineered tissues and equivalents in vitro,
including “vascularised” skin (Black et al., 1998; Germain
et al., 2000; Tonello et al., 2003), while other groups have
created cell models for vascularisation and capillary-
network formation to study various cell-cell, cell-matrix
(Sieminski et al., 2004) and cell-nutrient diffusion
interactions (Griffith et al., 2005).
There has been much work done on creating functional
macrovessels using bioreactors that utilize perfusion and
mechanical stimulation (Barron et al., 2003; Jeong et al.,
2005; McCulloch et al., 2004; Mironov et al., 2003;
Niklason et al., 2001; Niklason et al., 1999; Stegemann
and Nerem, 2003; Thompson et al., 2002). There is no
doubt that bioreactors are essential for the in vitro creation
of functional and viable tissues and vessels (Freed and
Vunjak-Novakovic, 2002; Martin et al., 2004; Niklason
and Seruya, 2002). For microvascular applications, some
groups have created microvessels using perfusion
bioreactor technologies (Neumann et al., 2003), while
others have used horizontal rotating bioreactors, such as
the one developed by NASA (Dutt et al., 2003).
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A traditional research area for investigating the
functionality of microvessels has been the use of the eye
system, for example in the diabetic retinopathy field. The
modulation of the transport barrier of MVEC (Haselton et
al., 1996) is definitely one of the defining functions of the
microvasculature. Functional responses to ischemia could
be simulated in culture environments to influence
arteriogenesis, collateral vessel formation, and increase
blood vessel density once bioengineered tissues are
vascularised (Helisch and Schaper, 2003).
However, comprehensive vascularisation of thick
tissues in vitro is hard to control and reproduce reliably.
From this point there is the next limitation of creating
proper connections of the bioengineered tissue with host
vasculature when the tissue is implanted.
Cell Types for In Vitro Vascular Analogues
Microvascular and macrovascular endothelial cells
In tissue engineering vasculature, stabilization of capillary-
like structures (CLS) is of utmost importance (Frerich et
al., 2001). Endothelium is most important in the
microcirculation, where exchange of gases, fluids,
nutrients, and waste products occurs. The endothelia of
capillaries most commonly exist as a continuous sheet,
but also can take the form of a sheet with fenestrations (in
small intestines, endocrine glands, and kidneys), or as a
discontinuous  sheet (in sinusoids of the liver) (Nguyen
and D’Amore, 2001; Sumpio et al., 2002).
Permeability regulation is important for microvessels
and capillaries (Haselton et al., 1996; Hellstrom et al.,
2001; Nguyen et al., 2001; Sumpio et al., 2002).
Fenestrations, caveolae, and pores are at the level of the
EC soma as well as gaps between EC. Fenestrations are
specialised areas of the EC plasma membrane that are
involved in permeability, and fenestrated endothelia are
found in microvessels associated with secretory and
absorptive epithelia, such as kidney glomeruli, endocrine
organs, and the gastrointestinal tract (Nguyen et al., 2001;
Sumpio et al., 2002). In contrast, EC found in connective
tissues, skin, muscle, lung, and brain have few, if any
fenestrations (Nguyen et al., 2001).
Endothelial cells exert significant paracrine and
endocrine actions through their influence on the underlying
SMC or on circulating blood elements, such as platelets
and white blood cells (Sumpio et al., 2002). EC are
normally quiescent in vivo and most in adults have a cell
cycle variable from months to years. However, following
an injury, cells change their phenotype, migrate and
proliferate to heal lesions in a few days (Bachetti and
Morbidelli, 2000).
EC also play direct roles in controlling the vascular
tone, blood flow and vascular permeability, especially in
the microvasculature (Bachetti and Morbidelli, 2000).
Various types of EC such as human umbilical vein EC
(HUVEC) (Tonello et al., 2003), rat microvascular EC
(Frye and Patrick, 2002), human dermal microvascular EC
(HDMEC) (Borges et al., 2003a; Nor et al., 2001; Richard
et al., 1998), bovine aortic EC (BAEC) (Dutt et al., 2003;
Vernon et al., 1995) and bovine capillary EC (BCEC)  have
been used for in vitro models of angiogenesis and
vasculogenesis (Karasek, 1989; Vailhe et al., 2001). The
immortalised HMEC line SV-40 HMEC-1 has also been
used (Ades et al., 1992; Liu et al., 2002; Meade-Tollin
and Van Noorden, 2000). Gelatin, fibrin, collagen,
fibronectin (Harding et al., 2002) and Matrigel (Meade-
Tollin and Van Noorden, 2000) have been used as matrices
for 2D and 3D culture studies. It has been noted though
that cultured EC rapidly undergo apoptosis following
implantation in vivo (Nomi et al., 2002).
The biochemical profile of microvascular and
macrovascular EC differ, indicating system-specific
functions and roles. For example the matrix
metalloproteinases (MMP) and tissue inhibitor of
metalloproteinases (TIMP) secretory profiles of cultured
microvascular compared to macrovascular tissues is
different (Jackson and Nguyen, 1997). For example
cytokeratin 8, 18, 19 and vimentin are cytoskeletal proteins
that are present on microvascular EC but not on
macrovascular EC (Bachetti and Morbidelli, 2000). The
ECM components produced by microvascular EC and
macrovascular EC are different, and are linked to the
different thrombogenic properties of the cells (Bonnefoy
et al., 2001). On a wider application focus, there are
differences in phenotype expression between primary cells
and cell lines as well (Unger et al., 2002).
Interaction of endothelial cells with smooth muscle
cells
Even though SMC are not typically associated with
capillaries, endothelial progenitor cells (EPC) have been
co-cultured with SMC to form microvessels on porous
polymer scaffolds in vitro (Wu et al., 2004) and it has been
reported that rat aortic SMC can become pericyte-like
during angiogenesis in vitro (Nicosia and Villaschi, 1995).
It has also been reported that, like EC, vascular SMC can
display blood vessel formation behavior in vitro when an
appropriate 3D matrix environment is provided to keep
them in a relatively higher-differentiated and low-
proliferative state (Song et al., 2000). An artificial method
to induce migration, and potentially CLS formation, of
EC has been to co-culture EC with VEGF-transfected SMC
or their conditioned media (Elbjeirami and West, 2006).
The significance of these observations for tissue
engineering is that SMC may be used in bioengineering
microvascular networks. However, the importance and
biological relevance of SMC over pericytes remains to be
determined since pericytes are the key supporting cells in
microvascular networks in vivo.
Pericytes
The origin of cells may be an important factor when
utilizing cells for specific tissues, and it is important to
use cells with the correct phenotype (Jackson and Nguyen,
1997). For undifferentiated cells though, this may not be
the case. For example, pericytes have been suggested to
have tissue-specific functions (Hirschi and D’Amore,
1996). Although tissue-specific cell functions can be shown
from cells that display plasticity, as has been demonstrated
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by various “tissue-specific” cell types (Rezai et al., 2004;
Tao and Ma, 2003).
Pericytes, also known as Rouget cells or mural cells,
are the microvascular correlates of SMC, lie within the
basement membrane and have processes that reach through
to contact the EC (Hirschi and D’Amore, 1996; Thomas,
1999). Morphologically, pericytes exhibit a small, oval cell
body with multiple processes extending for some distance
along the vessel axis. These primary processes then give
rise to orthogonal secondary branches which encircle the
vascular wall. Pericytes are precisely located adjacent to
or over EC junctions of venules and especially over gaps
between EC during inflammation (Sims, 2000). Of
functional importance, it has been reported that pericyte
inclusion in in vitro capillary permeability experiments
increases the capillary barrier effect (Dente et al., 2001).
Perivascular cells (pericytes and SMC) stabilise newly
formed capillaries and render them to matured structures
(Hirschi and D’Amore, 1996). Pericytes are most abundant
in venules, and common in capillaries (Nguyen et al., 2001;
Sims, 2000), and are suggested to be oligopotential and
reported to differentiate into adipocytes, osteoblasts,
macrophages, and phagocytes (Hirschi and D’Amore,
1996; Thomas, 1999). Microvessel pericytes seem to
exhibit several oxygen dependent, phenotypic
characteristics ascribed to osteoblasts (Reilly et al., 1998).
However, they are absent from growing vessels, implying
a role in down-regulating EC proliferation (Cassell et al.,
2002). Vessels that are associated with pericytes persist
independently of VEGF, whereas those lacking pericytes
regress following VEGF withdrawal (Carmeliet and
Conway, 2001; Carmeliet and Luttun, 2001).
The pericyte population is highly variable between
different tissues and organs, likely influenced by post-
arteriolar hydrostatic pressures, and are more abundant in
the distal legs and feet, suggesting a hydrostatic pressure-
driven mechanical role for pericytes as protectors of
microvessel wall integrity (Sims, 2000). This implies a
major role for perivascular mesenchymal cells for the
stabilization of newly formed vascular structures, and that
the use of perivascular cells is likely to be beneficial for in
vitro vascular bed systems, and to help create and maintain
a functional in vitro vascular bed template. Pericytes may
also function as macrophages, amongst other functional
roles. They can be contractile and seem to serve as a smooth
muscle equivalent in the capillaries performing
vasoconstriction, and they appear to directly participate
in coagulation through the extrinsic pathway (Thomas,
1999).
It has also been seen in vivo that monocytes and
macrophages can have the propensity for endothelial trans-
differentiation within Matrigel and may have a role in
formation of CLS (Anghelina et al., 2006a; Anghelina et
al., 2006b).
Stem cells & bone marrow stromal cells (BMSC)
Bone marrow-derived cells have been reported to induce
repair of tissue in vivo (Zantop et al., 2006; Zhou et al.,
2007). For vascularisation and re-vascularisation purposes,
precursor cells, such as endothelial precursor cells, have
been used to study angiogenesis (Laing et al., 2007a; Laing
et al., 2007b; Otani et al., 2002). BMSC have been used
for therapeutic angiogenesis in animal research for many
years (Choong et al., 2006; Kaigler et al., 2006a; Kruyt et
al., 2007; Short et al., 2003; Zhou et al., 2007). These can
form blood vessel-like structures consisting of endothelial
tubes supported by SMC in 3D matrix gels and in chick
embryo models (Nomi et al., 2002), retinal precursor cells
in ocular angiogenesis experiments (Dutt et al., 2003), and
EPC for in vivo ocular disease models (Otani et al., 2002).
Adult bone marrow (BM) contains cells capable of
differentiating along hematopoietic (Lin(+)) or non-
hematopoietic (Lin(-)) lineages. Lin(-) hematopoietic stem
cells (HSCs) have been shown to contain a population of
EPC capable of forming blood vessels (Otani et al., 2002).
In neonatal mouse eye experiments, Lin(-) BM cells and
astrocytes specifically interact with one another during
normal angiogenesis and pathological vascular
degeneration in the retina, and are extensively and stably
incorporated into the forming retinal vasculature (Otani et
al., 2002).
Current data suggest stromal progenitors in the BM in
situ are associated with the outer surfaces of blood vessels
and may share identity with vascular pericytes (Short et
al., 2003). In adult organisms, BM-derived cells do not
promote vascular growth by incorporating into vessel walls
but may function as supporting cells (Ziegelhoeffer et al.,
2004). The major contribution of BM cells to angiogenic
processes is not endothelial, but may come from
progenitors for periendothelial vascular mural and
hematopoietic effector cells (Rajantie et al., 2004).
Autologous BMSC implantation in a chronic hind limb
ischemia model in rats seems to induce a neo-vascular
response resulting in a significant increase in blood flow
to the ischemic limb, as well as spontaneously regenerating
the various components of muscular tissues (Al-Khaldi et
al., 2003). Use of BMSC and EC in scaffolds has seen the
regeneration of osseous defects (Kaigler et al., 2006a).
The relevance to vasculogenesis of these observations is
that use of BMSC would have benefits for both
vascularisation and whole tissue and organ regeneration
because BMSC could be used for vascularisation and organ
tissue growth. EPC as well as other BM-derived cells have
been shown to contribute to the growth of endothelium-
lined vessels (angiogenesis) as well as the expansion of
pre-existing collaterals (arteriogenesis) in ischemic disease
(Carmeliet and Luttun, 2001). In another study, the
microvessel density in ischemic hindlimbs in mice was
significantly higher in CD117+ cell-implanted mice than
in the total BM cell-implanted mice, and implicated as
playing a key role in therapeutic angiogenesis induced by
BM cell implantation (Li et al., 2003).
Other BM-derived cells such as BM-derived fibroblasts
and BM endothelial cells have been used in 3D scaffold
cultures with the aim of stimulating vascularisation and
tissue formation (Choong et al., 2006; Srouji et al., 2006).
Co-culture
The interaction of EC with other cell types in vivo has
been seen to promote and maintain vascularisation. The
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aim of using co-culture is to mimic the beneficial and
complex interactions between cells to create and maintain
vascularisation in vitro. However, the optimal combination
of cells, their ratios, and conditions are still unknowns.
When blood vessels grow, EC migrate out first and
assemble in a primitive network of immature channels
(angiogenesis). These nascent vessels only consist of EC,
and they rupture easily and are leaky, prone to regression,
and poorly perfused. If perfusion is to become functional,
the network must remodel into a vascular tree of mature
large vessels branching off into smaller capillaries,
whereby excess immature vessels are pruned. The
recruitment of periendothelial cells (PEC) (pericytes in
small vessels or SMC in larger vessels) around nascent
vessels essentially contributes to the remodelling and
maturation of the primitive vascular network
(arteriogenesis) (Dente et al., 2001; Hirschi and D’Amore,
1996; Sims, 2000). When PEC make contact with EC, the
EC stop dividing and migrating, and EC become quiescent,
acquire specialised differentiation properties, and survive
for longer (Carmeliet and Conway, 2001; Sims, 2000). PEC
stabilize vessels by producing ECM and tightening
junctions, regulating perfusion through vasomotion,
establish vascular barriers, and make vessels more resistant
to regression (Thomas, 1999), and they also help to
establish vascular branches and prevent aneurysmal vessel
dilation. PEC help to establish a more mature, functional
vascular network and are therefore targets for inducing
therapeutic angiogenesis (Carmeliet and Conway, 2001).
In co-culture studies of BAEC and human astrocytes,
regulation of extracellular angio-associated migratory cell
protein (AAMP) by astrocytes has been hypothesized to
aid in angiogenesis of the nervous system (Beckner et al.,
2002).
Microvascular EC can also be used for other purposes.
Porcine brain microvascular EC have been used to support
the in vitro expansion of human primitive hematopoietic
BM progenitor cells via cell-to-cell interactions and
colony-stimulating factors (Davis et al., 1995). These
examples highlight the complex roles that microvascular
cells play in vascular biology. It is therefore foreseen for
in vitro applications that the interactions between different
cell types in co-culture may provide beneficial cues for
forming stable vessels and tissues.
Additional questions for co-culture utilization for
vascularisation in vitro are not simply questions about cell-
cell interactions or cell-matrix interactions, but in situations
involving synthetic scaffolds, are the interactions and
behaviours of co-cultures with the scaffold material surface
(Choong et al., 2006). Fibroblasts are another cell type
that has been used in co-culture. Fibroblasts not only
function to sustain various organs and tissues as stroma
cells but also act directly to regulate adjacent cell behavior
including migration, proliferation, and differentiation. In
vitro results in collagen hydrogels suggest that fibroblasts
secrete soluble factors that can influence EC behaviours
relevant to the angiogenesis process with possible
implications for vascularization in fibroproliferative
conditions (Kuzuya and Kinsella, 1994). Without the
necessary survival signals, EC suspended in 3D gels in
vitro die, but the presence of non-EC improves, for
example, the survival of BAEC embedded within Matrigel
(Sieminski et al., 2002). EC have been shown to elongate
and form microvascular networks along lines of ECM
tension in fibroblast-containing culture gels (Sieminski et
al., 2002), and culture of BAEC with fibroblasts causes
them to elongate and enhance their survival in vitro
compared to control cultures without any other cells. A
mechanism for improved cell survival has been
hypothesized to be the direct physical contact between
BAEC and the fibroblasts (Kuzuya and Kinsella, 1994;
Sieminski et al., 2002). In a further example, in a disc
angiogenesis model with EC and fibroblasts, angiogenesis
is observed (Kowalski et al., 1992), and the results support
the need for co-culture for effective cell functioning.
Dermal fibroblasts are reported to produce angiogenic
growth factors (Griffith and Naughton, 2002). BAEC co-
cultured in collagen hydrogels with human skin fibroblasts
cause the EC to become spindle shaped and to organize
into a CLS within the collagen hydrogels. Interestingly,
fibroblast-conditioned medium also induces EC initially
to elongate and subsequently to organize into a CLS within
collagen hydrogels (Kuzuya and Kinsella, 1994). In
endothelialized skin equivalents, collagen biopolymer co-
cultured with human keratinocytes, dermal fibroblasts, and
umbilical vein EC have spontaneously formed CLS in a
highly differentiated ECM (Black et al., 1998). In vivo,
culture of human dermal microvascular EC (HDMVEC)
spheroids and preadipocytes in a fibrin matrix for a
specially adapted chorioallantoic membrane model have
resulted in vascularisation of the matrix, with a capillary
network forming consisting of the transplanted HDMVEC
(Borges et al., 2003b). However, some other tissues have
not experienced the same success, such as creating muscle
tissue with an in vivo pre-vascularised fibrin matrix (Bach
et al., 2006). For potential neuro-regeneration applications,
neurons and glioma cells have been seen to over-express
stem-cell factor which induces angiogenesis in vitro and
in vivo in response to tumour-induced brain injury
(Thomas, 2006). Scaffold-free multi-cell artificially-
created microtissues using combinations of myoblasts,
chondrocytes, myofibroblasts, cardiomyocytes and
HUVEC have been implanted in vivo and have developed
a vascular system (Kelm et al., 2006a; Kelm et al., 2006b).
This approach further illustrates the viability of utilizing
complex multiple cell types in the pursuit of creating viable
tissue engineered tissues.
Approaches to vascularising scaffolds
Vascularisation of new bioengineered tissue can be
accomplished in three ways. Upon implantation, vessels
from surrounding tissue can be induced to infiltrate the
tissue with such vessel growth promoted by including
growth factors in the polymer scaffold. These factors
diffuse into the local environment, where they encourage
existing blood vessels to grow into the scaffold with cells
growing in from both sides knotting together to form a
continuous vessel (Kannan et al., 2005; Sheridan et al.,
2000). But this approach is problematic as blood vessels
need time to infiltrate into tissues, and thereby this will
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predispose the tissue to ischemia as the cells wait for a
nutrient supply to reach them. Vessels may also grow from
within a scaffold seeded with EC to help enhance the rate
of vascularisation. This approach is based on the hypothesis
that the transplanted cells will form CLS and join with
inwards growing vessels from the host tissue and combine
with existing blood vessels to create a continuous vessel
(Kannan et al., 2005; Sheridan et al., 2000). This approach
is also associated with a time delay before vascular
perfusion can occur due to the time for the vessel network
within the scaffold to anastomose with the host vasculature.
There is also a third method where matrices are pre-
vascularised in vivo (Lokmic et al., 2007; Polykandriotis
et al., 2006; Polykandriotis et al., 2007), and though this
review focuses on in vitro methods it is important to apply
in vivo results and observations to in vitro applications.
Use of three-dimensional scaffolds
With the possible exception of blood, three-dimensional
(3D) scaffolds are essential for creating realistic tissues
and organs for regenerative medicine. Tissues exist as 3D
structures, but the traditional approach of growing cells in
tissue culture flasks is far removed from the in vivo
situation. Cells in vitro proliferate at a liquid/substratum
interface and primary tissue cells grown in tissue culture
flasks experience contact inhibition. This severely limits
the degree of total cellularity of the system (Long, 2000).
Design factors for control of 3D tissue engineering
constructs include (1) the required substrate and ECM
composition (materials), (2) composition and rates of tissue
development (rates), (3) cell types present, localisation and
segregation from each other (cell types), (4) tissue shape
and microscopic architecture (architecture), and (5) special
local tissue functional requirements (Brown, 2000; Chen
et al., 2001a). Some of the other elements to consider are
illustrated in Figure 2 (Seal et al., 2001).
Synthetic polymer scaffolds
Synthetic biodegradable polymer scaffolds have been a
material of choice to create scaffolds to support cell growth
for bioengineered tissues and organs because they are more
controllable from a compositional and materials processing
viewpoint than biological materials. The drawback is that
they may not be recognised by cells due to the absence of
biological signals. Scaffold architecture parameters such
as pore size, porosity, and surface area (surface-to-volume
ratio) are widely recognised as important parameters when
designing a scaffold (Cao et al., 2006; Mastrogiacomo et
al., 2006). Other structural features such as pore shape,
pore wall morphology, and interconnectivity between pores
are also important for cell seeding, migration, growth, mass
transport, gene expression, and new tissue formation in
3D (Ma and Choi, 2001; Mastrogiacomo et al., 2006;
Mikos and Temenoff, 2000).
To coarsely mimic vasculature, some scaffold designs
have incorporated grooves, microchannels and/or
orientated pores to aid in directing cell growth and
behaviour (Britland et al., 1996; Curtis and Wilkinson,
2001; Kaihara et al., 2000; Shen et al., 2006a; Shen et al.,
2006b). This strategy also extends to biological scaffolds
with lumens/channels (Sachlos et al., 2006; Sachlos et al.,
2003). Microchannels in scaffolds and cell culture
environments have been used to increase mass transfer of
nutrients and cellular metabolic wastes in and out of the
cell/scaffold mass (Kaihara et al., 2000; Leclerc et al.,
2004c; Sachlos et al., 2003; Shin et al., 2004), and
mathematical modelling has been used to create networks
with specific microfluidics and nutritional transfer (Leclerc
et al., 2004a; Leclerc et al., 2004c; Radisic et al., 2006).
Channels and microchannel networks not only have
applications in vascularising scaffolds and bioengineered
tissues (Grikscheit and Vacanti, 2002; Leclerc et al.,
2004c), or simply as blood vessel templates, but are also
suited for neural applications in growing peripheral nerves
Figure 2. Some of the biological and engineering design requirements of scaffolds for tissue regeneration. Adapted
from (Seal, et al., 2001).
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(Sundback et al., 2003). An application has been to create
branching structures of the vascular network following a
fractal geometry where it has been observed that EC
densities and degree of organisation are higher on scaffolds
with higher branching levels, or complexity (Vozzi et al.,
2004).
Soft lithography techniques such as stamps or channels
have been used to create scaffolds. Also used are techniques
such as self-assembled monolayers, microcontact printing,
patterning using microfluidic channels (Kim et al., 1998b),
laser microfabrication (Duncan et al., 2002) and laminar
flow patterning (Kane et al., 1999; Leclerc et al., 2004b;
Moldovan and Ferrari, 2002). Benefits of these approaches
are the immediate perfusion of living tissue via the
integrated “vascular” network, and that these can be used
to potentially create “vascularized” layered 3D structures
of any shape and size (Kaihara et al., 2000; Vacanti et al.,
2003).
Biodegradable and bioresorbable polymers have been
based primarily on clinically established products, such
as polylactides, polyglycolides, optically active and
racemic polylactides, and polycaprolactone (Hutmacher,
2001; Hutmacher et al., 2001). But there are other synthetic
materials being used including ones that are under clinical
investigation for regulatory approval as well as more novel
polymeric biomaterials that are being tested in vitro only,
such as peptide-based materials (Holmes, 2002).
Disadvantages of cellular solid fabrication methods, using
these synthetic polymers, such as solvent leaching, porogen
leaching, gas foaming, vacuum drying, and thermally
induced phase separation (TIPS) (Chen et al., 2002;
Hutmacher, 2001) are that pores are sometimes not
completely inter-connected. Pores may vary in size and
the thickness and length of pore walls and edges vary
depending on the solvent evaporation rate. The scaffolds
cannot be made with thick sections as deeply embedded
porogens become too distant from the surface and residual
porogen may be left in the final structure (Hutmacher,
2001). However, with the development of better techniques
to ensure porogen connectivity and therefore pore
interconnectivity, such as porogen fusion, there has been
progress made into creating better cellular solids scaffolds
(Murphy et al., 2002). Alternatively, precise computer-
controlled manufacturing methods such as fused deposition
modelling can create porous scaffolds (Zein et al., 2002).
This can be used, for example, to create knitted textile
scaffolds with specific woven geometries (Wintermantel
et al., 1996).
Biological scaffolds
Biological materials are utilised in tissue engineering due
to the fact that there are many beneficial interactions
between these materials with cells. Natural materials are
readily recognised by cells, but the drawbacks to using
these materials include their poor mechanical properties.
Interactions between cells and biological ECM are catalysts
to cell migration, proliferation, differentiation, and
apoptosis, which are all critical functions in tissues
(Grikscheit and Vacanti, 2002). Mechanical strength of
tissues derives in a major part from the ECM and
production of matrix, and matrix production can be
manipulated (Edelman, 1999). Biomechanical tension
between EC and matrix may serve to regulate capillary
development since mechanical forces exerted by the cells
onto the matrix drive its reorganisation into cords and
subsequent CLS formation (Vailhe et al., 2001).
Collagen is an important ECM molecule (Kleinman et
al., 1982), and is the major structural component in the
body, comprising up to 25% of the dry protein (Brown,
2000). Collagen is an important part of the structure and
formation of vasculature, so it makes biomimetic sense to
use collagen for bioengineered vascularized tissues. Of
interest for in vitro utilization of collagens, types I and IV
are equally active both in native and denatured forms
(Kleinman et al., 1982). There are also very few
interspecies differences in the structure of type I collagen.
The extensive homology of the structure of type I collagen
means that when sourced from animal species it is
acceptable as a material for human transplantation (Li,
2003). For tissue engineering applications, collagen
hydrogels are formed via fibrillogenesis of soluble collagen
and have a random orientation and distribution, producing
an isotropic gel (Brown, 2000). Porous collagen matrices
are made by freeze-drying aqueous collagen solutions or
dispersions. Freeze-dried matrices require chemical cross-
linking to stabilize the structure where the rate of freezing,
the size of fibres in the dispersion, and the presence and
absence of other macromolecules contribute to the pore
structure (Li, 2003).
Growth factor delivery using collagen hydrogels is
another benefit of utilizing this biological material. For
example, loading of basic fibroblast growth factor into
heparin sulphate-attached (Pieper et al., 2002) or
glycosaminoglycan (GAG)-attached (Geutjes et al., 2006)
cross-linked collagen matrices has seen improved long
term vascularisation of hydrogels in vivo. In mice
implantation studies, VEGF incorporation into cross-linked
collagen hydrogels has seen significant angiogenesis
around implants (Tabata et al., 2000) and into the scaffolds
(Nillesen et al., 2007). Cell delivery using collagen
hydrogel has been utilized with, for example, a skeletal
muscle cell line and type 1 collagen hydrogel scaffold
constructed in vitro and implanted into nude mice to
vascularize it in vivo (Okano and Matsuda, 1998) as well
as with bone-marrow derived mesenchymal stem cells
(BM-MSC) implanted into mice that has shown increased
cellularity and vascularisation (Markowicz et al., 2006).
In contrast, viable tissues have also been seen in
transplanted un-prevascularised cells in collagen matrices,
where EC have rapidly infiltrated the tissue (Zhao et al.,
2005).
The relative magnitudes of cellular force generation
and apparent collagen hydrogel matrix stiffness seem to
modulate capillary morphogenesis in vitro. This balance
may play a role in regulating angiogenesis in vivo. In
constrained collagen hydrogels EC have appeared spread,
formed structures with fewer cells, had larger, thinner-
walled lumens than in floating (unconstrained) hydrogels,
and showed prominent actin stress fibers not seen in
floating gels (Sieminski et al., 2004).
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Collagen hydrogels have also been used extensively
for engineering macrovessels for cardiovascular
applications (Nerem et al., 1998; Seliktar and Nerem,
2002). Approaches have included the use of cross-linked
hydrogels to create mechanically strong vessels (Berglund
et al., 2003), use of SMC cultured in collagen hydrogels
(Song et al., 2000; Stegemann and Nerem, 2003a), ECs
co-cultured with SMC (Imberti et al., 2002), the use of
mechanical stimulation regimes, such as cyclical radial
distension and/or shear stress, in bioreactors (Braddon et
al., 2002; Chappell et al., 1998; Hoerstrup et al., 2001;
Imberti et al., 2002; Nerem et al., 1998; Thomas et al.,
2002; Ziegler et al., 1995), as well as the use of various
biochemical growth factors to help create a biomimetic
vessel substitute (Imberti et al., 2002; Stegemann and
Nerem, 2003b; Stegemann and Nerem, 2003a). There have
also been studies where collagen and fibrin hydrogels
loaded with VEGF and exposed to low interstitial fluid
flow result in the formation of different CLS structures
(Helm et al., 2007) giving rise to the importance of the
specific matrix composition on CLS structure.
To influence the structure of collagen hydrogels, cells
in collagen hydrogels can be exposed to mechanical
uniaxial stimulation to aid in aligning cells and fibres in a
certain direction. High density magnetic fields have also
been used to align collagen hydrogel fibres during
fibrillogenesis (Dickinson et al., 1994; Guido and
Tranquillo, 1993), however, controlling the structure of
the collagen hydrogel fibrils at such an early stage has not
been conclusively beneficial. This may be because cells,
in response to external cues, will respond accordingly to
remodel their environment.
Hybrid scaffolds
The need for hybrid natural/synthetic scaffolds stems from
the need to meet the demands for a scaffold system that
cells respond to favourably as well as being reliably and
repeatedly manufacturable to a consistent quality, and have
controllable structural and chemical composition for
creating bioengineered organs in vitro. These criteria
encompass elements such as:
1.  a surface that promotes cell adhesion, promotes cell
growth and allows the retention of differentiated cell
phenotypes,
2.  biocompatible, and the by-products should not be
toxic or provoke inflammation in vivo,
3.  biodegradable, and eventually eliminated from the
body,
4.  porosity should be high enough to provide sufficient
space for cell adhesion, ECM regeneration and allow
maximal diffusion during culture,
5. pore structures that allow even spatial cell
distribution throughout the scaffold to facilitate
homogeneous tissue formation, and
6.  the material should be reproducibly processable into
3D structures, and be mechanically strong (Chen et
al., 2002).
The motivation for hybrid natural/synthetic scaffolds
has been to combine the benefits of ease of processing,
structure control, and relatively good mechanical strength
of synthetic polymers, with the benefits of beneficial cell
interactions and hydrophilicity of biological matrices like
collagen. The most common method of hybridizing
collagen with synthetic polymer scaffolds has been to coat
the scaffold with a collagen gel that becomes a sponge
(Chen et al., 2004a; Chen et al., 2003; Chen et al., 2004b;
Chen et al., 2000; Chen et al., 2001a; Chen et al., 2002).
Biological molecules, such as fibronectin (Harding et al.,
2002) and VEGF (Elcin and Elcin, 2006; Kaigler et al.,
2006b), have also been used to coat synthetic polymer
scaffolds for growing vessels.
Bridging the in vivo / in vitro gap
Concept
For a bioengineered organ to be clinically relevant, it needs
to be able to be seamlessly integrated when implanted into
the patient. There needs to be a system that prevents cell
death due to the changes in perfusion quality during the
transferral from an in vitro system (i.e. bioreactor) to the
in vivo system (i.e. circulatory system). Currently there
are techniques that vascularise pre-shaped tissues in vivo
before autologously transplanting to another site on the
body (MacLeod et al., 2003; Tan et al., 2004), but this
causes donor site morbidity and so is therefore less than
ideal.
To address these issues, we have integrated five
elements from current approaches, which have been
commonly used separately in the literature, as a novel
approach to vascularising tissue analogues in vitro. The
first two components are the incorporation of multiple
macro-lumens lumens (Kaihara et al., 2000; Leclerc et al.,
2004b; Sachlos et al., 2006; Sachlos et al., 2003; Shin et
al., 2004), in porogen-fused, highly porous and
interconnected biodegradable synthetic polymer scaffolds
(Gao et al., 2006; Murphy et al., 2002) to aid in increasing
access to nutrients for cells within the scaffold, as well as
creating “vessels” that can be used to connect to host
vasculature on implantation. The third component is the
use of collagen hydrogel as a cell delivery vehicle into the
porous scaffolds. The collagen is also the biological matrix
that will support cell growth, migration, and vascularisation
behaviour of microvascular cells. Figure 3 illustrates the
components of this system, where a porous polymer
scaffold is combined with cells and biological matrix to
direct cell behaviour and eventual tissue growth. The fourth
component is the use of co-cultures of EC with other cell
types to investigate the interaction between the various
cells, scaffold, and formed microvessels in the system
(Beckner et al., 2002; Black et al., 1998; Dente et al., 2001;
Imegwu et al., 2001; Kuzuya and Kinsella, 1994). An
analogue that can be created with co-culture is bone, via
the incorporation of BMSC (Choong et al., 2006; Kaigler
et al., 2006a; Kruyt et al., 2007; Short et al., 2003; Zhou
et al., 2007). In fact the use of BMSC has been reported to
secrete sufficient quantities of VEGF to enhance survival
and differentiation of EC in vitro (Kaigler et al., 2003).
The use of BMSC itself has been used for
neovascularisation (Kinnaird et al., 2004; Li et al., 2003).
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The fifth component is the use of a dynamic culture
environment to provide biomechanical stimulation to the
cells within the scaffold, as well as to provide increased
mixing of cell culture nutrient media for compositional
homogeneity. It has been reported that modalities such as
flow perfusion (van den Dolder et al., 2003) on BM cells
has beneficial effects on proliferation and differentiation.
The combination of high scaffold porosity and fluid flow
minimizes diffusion constraints enhances differentiation
of BMSC (Gomes et al., 2006).
Collagen infusion and cell attachment
An important aspect of growing tissues in vitro has been
for cells to be distributed homogeneously throughout the
scaffold. This is a traditional consideration in animal cell
culture to prevent heterogeneous localised cell growth and
behaviour within the same growth environment. Methods
such as dynamic perfusion (Li et al., 2001; Sodian et al.,
2002; Wendt et al., 2003), centrifugal force (Godbey et
al., 2004; Yang et al., 2001), rotation (Nasseri et al., 2003),
magnetic cell seeding (Perea et al., 2006) and stirring/
agitation (Kim et al., 1998a) have been used with some
success. By using a collagen hydrogel cell delivery system,
cells can be homogeneously and randomly distributed
throughout a carrier matrix, and then infused into a
scaffold. This is similar to the methods using fibrin gel to
deliver cells to polyglycolic acid (PGA) scaffolds (Ameer
et al., 2002) and Matrigel to deliver cells into collagen
sponges (Radisic et al., 2003). The use of a hydrogel
infusion cell delivery vehicle is very useful for slow
attaching primary cells because with standard cell
attachment-dependent cell seeding techniques, the
probability of losing cells from a porous synthetic scaffold
with a short incubation period is high. It has been shown
that using collagen microsponges increases cell seeding
efficiency (Chen et al., 2004b). Collagen is chemotactic
and capable of stimulating further deposition of more
matrix proteins (Kleinman et al., 1982). Collagen also has
the advantages of being a biological ECM and has a history
of being used effectively in cardiovascular tissue
engineering applications (Berglund et al., 2003; Imberti
et al., 2002; Nasseri et al., 2003; Nillesen et al., 2007;
Stegemann and Nerem, 2003a; Thomas et al., 2003). We
synthesize and use kangaroo tail tendon as a source of
collagen due to the high collagen yield per animal
compared to other species. Traditionally, yield of collagen
is extremely variable and dependent on the animal species
and the age of the animal. Very low yields from human
skin to higher yields in young rat skin of up to 60% have
been reported (Bazin and Delaunay, 1976) with the richest
sources of collagen fibres being from the skin and tendons
of adult mammals (Steven, 1976). However, if we consider
total yield per animal tissue sample, especially in the face
of animal ethics considerations, use of kangaroo tail is the
most economical and high yield source. Also, use of
relatively young animals is important as the proportion of
insoluble collagen in most organs increases with age and
can be affected by a number of physiological and
pathophysiological situations (Deyl and Adam, 1976).
Figure 4 shows a porous 5wt%/vol poly DL-lactic-co-
glycolic acid (P(DL)LGA) (75:25) scaffold with 53-106µm
pores that has been cut in half showing collagen fibres
dispersed within the scaffold pores. Another benefit of
using hydrogel cell delivery is that the hydrogel can also
incorporate relevant growth factors to stimulate tissue-
specific growth (Park et al., 2007) as well as for cell
delivery. Figure 5 shows human microvascular cells SV-
40 HMEC-1 showing clear alignment within a cell/collagen
hydrogel/scaffold system.
Optimization of system parameters
Mass transfer has been a serious problem for thick tissues
that do not attempt to include some sort of vascular supply
or inherent channel structures throughout the scaffold to
Figure 3. Components of the
hybrid scaffold system based on
collagen hydrogel cell delivery
into a highly intereconnected and
porous synthetic biodegradable
polymer scaffold. (A), (B), and
(C) show cross-sections of the
lumens and pores. (A) illustrates
collagen infused into the pores
of the scaffold, while (B) shows
a mixture of microvascular and
other cells with collagen in the
pores. (C) shows the formation
of microvessels in the scaffold
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allow nutrients and wastes to diffuse. The use of macro-
lumens and other similar channels is an inherent structural
method to aid in creating better access to nutrients for cells
within a scaffold (Kaihara et al., 2000; Kannan et al., 2005;
Kim et al., 1998b; Moldovan and Ferrari, 2002; Schantz
et al., 2005; Shin et al., 2004; Vacanti et al., 2003). With
an optimal cell seeding and cell/scaffold culturing
condition, such as dynamic cell seeding followed by
bioreactor culture (Burg et al., 2000), neovascularisation
might be able to occur fast enough in highly porous
scaffolds.
However there is a limit to this as there is an access
gradient from the cells at the surface, which have the best
access to nutrients, to the cells further away from the
surface. However, it may be theorised that this may not be
as big a disadvantage as it first seems. Since angiogenesis
forms due to ischemia and nutrient/oxygen gradients in
tissues, this nutrient/oxygen gradient in cell/matrix/scaffold
systems may actually promote vessel in-growth and
formation. The extent of mass transfer limitation can also
be controlled to some extent by changing the concentration
of the collagen hydrogel. Another method that we are
testing is the use of anisotropic pore scaffolds which will
minimize the tortuosity of the scaffold pore structure and
therefore increase mass transfer. Figure 6 shows a scanning
electron micrograph of equine BMSC cultured on one such
anisotropic pore 5wt%/vol P(DL)LGA scaffold created
using a TIPS method (Cao et al., 2003; Cao et al., 2006).
Clearly seen are multiple black pores on the surface of the
cell/scaffold construct. We are comparing the cell viability
and distribution characteristics of this design with the
standard highly interconnected and porous isotropic
scaffolds. Another option for increasing mass transfer of
oxygen could be to use cell culture media additives such
as perfluorocarbon to enhance the supply of oxygen to
cells (Radisic et al., 2006) or the use of novel molecules
for therapeutic angiogenesis (Sengupta et al., 2004).
Optimization of the tools of tissue engineering used
such as scaffolds, bioreactors and molecular and physical
signalling is complex and requires a multidisciplinary
approach and team of researchers and collaborators (Freed
et al., 2006; Mikos et al., 2006). It is hoped that this current
combinatorial approach will contribute to the research in
bioengineered tissue vascularisation in vitro. One aspect
that needs to be addressed further is the anisotropic nature
of vascularisation and to design scaffolds and bioreactor
systems that can mimic or nurture the potential to
accommodate this anisotropy (Borselli et al., 2007; Lanza
et al., 2006). These biomechanical influences will in turn
affect the remodelling of the vascular structures (Jones et
al., 2006).
Figure 4. SEM of 4mg/mL collagen hydrogel infused
5wt%/vol P(DL)LGA(75:25) scaffold with 53-106µm
diameter pores. Samples were processed from
cryohistology. Black star (*) indicates some of the
collagen fibers from the dehydrated hydrogel.
Figure 5. Haematoxylin and eosin-stained SV-40
HMEC-1 within 4mg/mL collagen hydrogel infused
within a porous 5wt%/vol P(L)LA scaffold 53-106µm
diameter pores. Outlined regions show that there is
clearly anisotropic cell alignment and aligned cell
clustering. 4 week static culture.
Figure 6. Equine BMSC cultured on a porous
anisotropic pore 5wt%/vol P(DL)LGA scaffold with
~200µm diameter pores. Even though the surface is
populated with BMSC and it’s matrix, there are clearly
visible pore openings (black holes). 5 day static culture.
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Conclusions
The current trend in vascularising bioengineered tissues
is the integration of various parameters that have been
observed from in vivo biological research and in vitro
bioengineering research. These include combining design
parameters of highly porous macro- and micro-channelled
polymeric scaffolds, the use of biological ECM matrices
such as collagen hydrogels, microvascular cells co-cultured
with other cells or growth factors, and culturing the cell/
scaffold constructs in biomechanically dynamic
environments. Microvascular cell co-culture with collagen
hydrogel infusion in a highly interconnected and porous
polymeric scaffold containing macro-lumens is one such
integrated parameter system for creating a vascularized
tissue. Benefits include the provision of a 3D matrix for
cells to immediately adhere to within the scaffold, and
gelling within a scaffold ensures cell entrapment within
the scaffold. Potential drawbacks include a reduction of
mass transfer ability to central regions of scaffold, but this
factor may be beneficial given that angiogenesis occurs in
response to ischemia. With a combinatorial approach, many
growth parameters and interactions will need to be
optimized before a true vascular analogue can be viably
developed and maintained in vitro for tissue engineering.
Finally, the ability to create a vascular analogue in vitro is
very important to ensuring the viability and functionality
of bioengineered organs, as is the capacity to connect to
host vasculature upon implantation.
Acknowledgements
This project was funded by a Discovery Grant from the
Australian Research Council. Thanks to Ms Pankaj Godara
and A/Prof. John Whitelock (University of New South
Wales) for discussions on collagen processing, and Prof.
Justin Cooper-White and Ms Sue-Ann Lim (University of
Queensland) for discussions on scaffold designs and supply
of anisotropic scaffolds.
References
Ades EW, Candal FJ, Swerlick RA, George VG,
Summers S, Bosse DC, Lawley TJ (1992) HMEC-1
establishment of an immortalised human microvascular
endothelial cell line. J Invest Dermatol 99: 683-690.
Ahrendt G, Chickering DE, Ranieri JP (1998)
Angiogenic growth factors. Tissue Eng 4: 117-130.
Al-Khaldi A, Al-Sabti H, Galipeau J, Lachapelle K
(2003) Therapeutic angiogenesis using autologous bone
marrow stromal cells: Improved blood flow in a chronic
limb ischemia model. Ann Thorac Surg 75: 204-209.
Ameer GA, Mahmood TA, Langer R (2002) A
biodegradable composite scaffold for cell transplantation.
J Orthop Res 20: 16-19.
Anghelina M, Krishnan P, Moldovan L, Moldovan NI
(2006a) Monocytes/macrophages cooperate with
progenitor cells during neovascularization and tissue repair
- Conversion of cell columns into fibrovascular bundles.
Am J Pathol 168: 529-541.
Anghelina M, Moldovan L, Zabuawala T, Ostrowski
MC, Moldovan NI (2006b) A subpopulation of peritoneal
macrophages form capillary-like lumens and branching
patterns in vitro. J Cell Mol Med 10: 708-715.
Auerbach R, Auerbach W (2002) Vasculogenesis and
angiogenesis. In: The New Angiotherapy (Fan TPD, Kohn
EC, eds) Humana Press, Totowa NJ. pp 1-6.
Bach AD, Arkudas A, Tjiawi J, Polykandriotis E,
Kneser U, Horch RE, Beier JP (2006) A new approach to
tissue engineering of vascularised skeletal muscle. J Cell
Mol Med 10: 716-726.
Bachetti T, Morbidelli L (2000) Endothelial cells in
culture: A model for studying vascular functions. Pharm
Res 42: 9-19.
Barron V, Lyons E, Stenson-Cox C, McHugh PE,
Pandit A (2003) Bioreactors for cardiovascular cell and
tissue growth: a review. Ann Biomed Eng 31: 1017-1030.
Bazin S, Delaunay A (1976) Preparation of acid and
citrate soluble collagen. In: The Methodology of
Connective Tissue Research (Hall DA, ed) Joynson and
Bruwers, Oxford, UK. pp. 13-17.
Beckner ME, Jagannathan S, Peterson VA (2002)
Extracellular angio-associated migratory cell protein plays
a positive role in angiogenesis and is regulated by
astrocytes in coculture. Microvasc Res 63: 259-269.
Berglund JD, Mohseni MM, Nerem RM, Sambanis A
(2003) A biological hybrid model for collagen-based tissue
engineered vascular constructs. Biomaterials 24: 1241-
1254.
Black AF, Berthod F, L’Heureux N, Germain L, Auger
FA (1998) In vitro reconstruction of a human capillary-
like network in a tissue-engineered skin equivalent. FASEB
J 12: 1331-1340.
Bonnefoy A, Harsfalvi J, Pfliegler G, Fauvel-Lafeve
F, Legrand C (2001) The subendothelium of the HMEC-1
cell line supports thrombus formation in the absence of
von Willebrand factor and collagen types I, III and VI.
Thromb Haemostasis 85: 552-559.
Borges J, Mueller MC, Padron NT, Tegtmeier F, Lang
EM, Stark GB (2003a) Engineered adipose tissue supplied
by functional microvessels. Tissue Eng 9: 1263-1270.
Borges J, Tegtmeier FT, Padron NT, Mueller MC, Lang
EM, Stark GB (2003b) Chorioallantoic membrane
angiogenesis model for tissue engineering: A new twist
on a classic model. Tissue Eng 9: 441-450.
Borselli C, Oliviero O, Battista S, Ambrosio L, Netti
PA (2007) Induction of directional sprouting angiogenesis
by matrix gradients. J Biomed Mat Res 80A: 297-305.
Braddon LG, Karoyli D, Harrison DG, Nerem RM
(2002) Maintenance of a functional endothelial cell
monolayer on a fibroblast/polymer substrate under
physiologically relevant shear stress conditions. Tissue Eng
8: 695-708.
Britland S, Morgan H, Wojiak-Stodart B, Riehle M,
Curtis A, Wilkinson C (1996) Synergistic and hierarchical
adhesive and topographic guidance of BHK cells. Exp Cell
Res 228: 313-325.
Brown RA (2000) Bioartificial implants: design and
tissue engineering. In: Structural Biological Materials
(Elices M, ed), Vol 4. Elsevier, Oxford, UK. pp 107-157.
13
HCH Ko et al.                                                                                                                         Vascularisation when engineering thick tissues
Burg KJ, Holder WD, Jr., Culberson CR, Beiler RJ,
Greene KG, Loebsack AB, Roland WD, Eiselt P, Mooney
DJ, Halberstadt CR (2000) Comparative study of seeding
methods for three-dimensional polymeric
scaffolds.[erratum appears in J Biomed Mater Res 2000
Dec 5;52(3):following 575]. J Biomed Mat Res 51: 642-
649.
Cao Y, Croll TI, Cooper-White JJ, O’Connor AJ,
Stevens GW (2003) Production and surface modification
of polylactide-based polymeric scaffolds for soft-tissue
engineering. Biopolymer Meth Tissue Eng 238 87-111.
Cao Y, Mitchell G, Messina A, Price L, Thompson E,
Penington A, Morrison W, O’Connor A, Stevens G,
Cooper-White J (2006) The influence of architecture on
degradation and tissue ingrowth into three-dimensional
poly(lactic-co-glycolic acid) scaffolds in vitro and in vivo.
Biomaterials 27: 2854-2864.
Carmeliet P, Conway EM (2001) Growing better blood
vessels. Nature Biotech 19: 1019-1020.
Carmeliet P, Lutton A (2001) The emerging role of the
bone marrow-derived stem cells in (therapeutic)
angiogensis. Thromb Haemostasis 86: 289-297.
Cassell OC, Hofer SO, Morrison WA, Knight KR
(2002) Vascularisation of tissue-engineered grafts: the
regulation of angiogenesis in reconstructive surgery and
in disease states. Brit J Plast Surg 55: 603-610.
Chappell DC, Varner SE, Nerem RM, Medford RM,
Alexander RW (1998) Oscillatory shear stress stimulates
adhesion molecule expression in cultured human
endothelium. Circ Res 82: 532-539.
Chen G, Ushida T, Tateishi T (2001a) Development of
biodegradable porous scaffolds for tissue engineering. Mat
Sci Eng: C17: 63-69.
Chen G, Sato T, Ushida T, Hirochika R, Ochiai N,
Tateishi T (2004a) Regeneration of cartilage tissue by
combination of canine chondrocyte and a hybrid mesh
scaffold. Mat Sci Eng: C24: 373.
Chen G, Sato T, Ushida T, Hirochika R, Shirasaki Y,
Ochiai N, Tateishi T (2003) The use of a novel PLGA fiber/
collagen composite web as a scaffold for engineering of
articular cartilage tissue with adjustable thickness. J
Biomed Mater Res A 67: 1170-1180.
Chen G, Sato T, Ushida T, Ochiai N, Tateishi T (2004b)
Tissue engineering of cartilage using a hybrid scaffold of
synthetic polymer and collagen. Tissue Eng 10: 323-330.
Chen G, Ushida T, Tateishi T (2000) A biodegradable
hybrid sponge nested with collagen microsponges. J
Biomed Mater Res 51: 273-279.
Chen G, Ushida T, Tateishi T (2001b) Poly(DL-lactic-
co-glycolic acid) sponge hybridized with collagen
microsponges and deposited apatite particulates. J Biomed
Mater Res 57: 8-14.
Chen G, Ushida T, Tateishi T (2002) Scaffold design
for tissue engineering. Macromol Biosci 2: 67-77.
Choong CS, Hutmacher DW, Triffitt JT (2006) Co-
culture of bone marrow fibroblasts and endothelial cells
on modified polycaprolactone substrates for enhanced
potentials in bone tissue engineering. Tissue Eng 12: 2521-
2531.
Curtis A, Wilkinson C (2001) Nantotechniques and
approaches in biotechnology. Trends Biotechnol 19: 97-
101.
Davis TA, Robinson DH, Lee KP, Kessler SW (1995)
Porcine brain microvascular endothelial cells support the
in vitro expansion of human primitive hematopoietic bone
marrow progenitor cells with a high replating potential:
requirement for cell-to-cell interactions and colony-
stimulating factors. Blood 85: 1751-1761.
Dente CJ, Steffes CP, Speyer C, Tyburski JG (2001)
Pericytes augment the capillary barrier in in vitro
cocultures. J Surg Res 97: 85-91.
Deyl Z, Adam M (1976) Preparation of insoluble
collagen. In: The Methodology of Connective Tissue
Research (Hall DA, ed). Joynson and Bruwers, Oxford,
UK. pp 1-17.
Dickinson RB, Guido S, Tranquillo RT (1994) Biased
cell migration of fibroblasts exhibiting contact guidance
in oriented collagen gels. Ann Biomed Eng 22: 342-356.
Downs KM (2003) Florence Sabin and the mechanism
of blood vessel lumenization during vasculogenesis.
Microcirculation 10: 5-25.
Duncan AC, Weisbuch F, Rouais F, Lazare S, Baquey
C (2002) Laser microfabricated model surfaces for
controlled cell growth. Biosens Bioelectron 17: 413.
Dutt K, Sanford G, Harris-Hooker S, Brako L, Kumar
R, Sroufe A, Melhado C (2003) Three-dimensional model
of angiogenesis: Coculture of human retinal cells with
bovine aortic endothelial cells in the NASA bioreactor.
Tissue Eng 9: 893-908.
Edelman ER (1999) Vascular tissue engineering:
designer arteries. Circ Res 85: 1115-1117.
Elbjeirami WM, West JL (2006) Angiogenesis-like
activity of endothelial cells co-cultured with VEGF-
producing smooth muscle cells. Tissue Eng 12: 381-390.
Elcin AE, Elcin YM (2006) Localized angiogenesis
induced by human vascular endothelial growth factor-
activated PLGA sponge. Tissue Eng 12: 959-968.
Egginton S, Gerritsen M (2003) Lumen formation: in
vivo versus in vitro observations. Microcirculation 10: 45-
61.
Eiselt P, Kim BS, Chacko B, Isenberg B, Peters MC,
Greene KG, Roland WD, Loebsack AB, Burg KJ,
Culberson C, Halberstadt CR, Holder WD, Mooney DJ
(1998) Development of technologies aiding large-tissue
engineering. Biotechnol Progr 14: 134-140.
Folkman J, Haudenschild C (1980) Angiogenesis in
vitro. Nature 288: 551-556.
Freed LE, Guilak F, Guo XE, Gray ML, Tranquillo R,
Holmes JW, Radisic M, Sefton MV, Kaplan D, Vunjak-
Novakovic G (2006) Advanced tools for tissue
engineering: Scaffolds, bioreactors, and signaling. Tissue
Eng 12: 3285-3305.
Freed LE, Vunjak-Novakovic G (2002) Cell-polymer-
bioreactor systems. In: Methods of Tissue Engineering
(Atala  A, Lanza, R eds), Elsevier, Amsterdam.  pp 99-
114.
Frerich B, Lindemann N, Kurtz-Hoffmann J, Oertel K
(2001) In vitro model of a vascular stroma for the
engineering of vascularized tissues. Int J Oral Maxillof
30: 414-420.
14
HCH Ko et al.                                                                                                                         Vascularisation when engineering thick tissues
Frye CA, Patrick Jr CW (2002) Isolation and culture
of rat microvascular endothelial cells. In Vitro Cell Dev-
An 38: 208-212.
Germain L, Remy-Zolghadri M, Auger F (2000) Tissue
engineering of the vascular system: from capillaries to
larger blood vessels. Med Biol Eng Comput 38: 232-240.
Gao J, Crapo PM, Wang Y (2006) Macroporous
elastomeric scaffolds with extensive micropores for soft
tissue engineering. Tissue Eng 12: 917-925.
Geutjes PJ, Daamen WF, Buma P, Feitz WF, Faraj KA,
van Kuppevelt TH (2006) From molecules to matrix:
construction and evaluation of molecularly defined
bioscaffolds. Adv Exp Med Biol 585: 279-295.
Godbey WT, Hindy SB, Sherman ME, Atala A (2004)
A novel use of centrifugal force for cell seeding into porous
scaffolds. Biomaterials 25: 2799-2805.
Gomes ME, Holtorf HL, Reis RL, Mikos AG (2006)
Influence of the porosity of starch-based fiber mesh
scaffolds on the proliferation and osteogenic differentiation
of bone marrow stromal cells cultured in a flow perfusion
bioreactor. Tissue Eng 12: 801-809.
Gridley T (2007) Vascular biology: vessel guidance.
Nature 445: 722-723.
Griffith CK, Miller C, Sainson RC, Calvert JW, Jeon
NL, Hughes CC, George SC (2005) Diffusion limits of an
in vitro thick prevascularized tissue. Tissue Eng 11: 257-
266.
Griffith LG, Naughton G (2002) Tissue engineering –
current challenges and expanding opportunities. Science
295: 1009-1014.
Grikscheit TC, Vacanti JP (2002) The history and
current status of tissue engineering: The future of pediatric
surgery. J Pediatr Surg 37: 277-288.
Grounds MD (2000) Muscling in on tissue engineering.
Today’s Life Science. November/December: 36-40.
Guido S, Tranquillo RT (1993) A methodology for the
systematic and quantitative study of cell contact guidance
in oriented collagen gels. Correlation of fibroblast
orientation and gel birefringence. J Cell Sci 105: 317-331.
Harding SI, Afoke A, Brown RA, MacLeod A, Shamlou
PA, Dunnill P (2002) Engineering and cell attachment
properties of human fibronectin-fibrinogen scaffolds for
use in tissue engineered blood vessels. Bioprocess Biosyst
Eng 25: 53-59.
Haselton FR, Dworska E, Evans SS, Hoffman LH,
Alexander JS (1996) Modulation of retinal endothelial
barrier in an in vitro model of the retinal microvasculature.
Exp Eye Res 63: 211-222.
Hellstrom M, Gerhardt H, Kalen M, Li XR, Eriksson
U, Wolburg H, Betsholtz C (2001) Lack of pericytes leads
to endothelial hyperplasia and abnormal vascular
morphogenesis. J Cell Biol 153: 543-553.
Helisch A, Schaper W (2003) Arteriogenesis: the
development and growth of collateral arteries.
Microcirculation 10: 83-97.
Helm CLE, Zisch A, Swartz MA (2007) Engineered
blood and lymphatic capillaries in 3-D VEGF-fibrin-
collagen matrices with interstitial flow. Biotech Bioeng
96: 167-176.
Hirschi KK, D’Amore PA (2996) Pericytes in the
microvasculature. Cardiovasc Res 32: 687-698.
Hoerstrup SP, Zund G, Sodian R, Schnell AM,
Grunenfelder J, Turina MI (2001) Tissue engineering of
small caliber vascular grafts. Eur J Cardio-Thorac Surg
20: 164-169.
Holmes TC (2002) Novel peptide-based biomaterial
scaffolds for tissue engineering. Trends Biotechol 20: 16-
21.
Hutmacher DW (2001) Scaffold design and fabrication
technologies for engineering tissues – state of the art and
future perspectives. J Biomater Sci, Polymer Ed 12: 107-
124.
Hutmacher DW, Schantz T, Zein I, Ng KW, Teoh SH,
Tan KC (2001) Mechanical properties and cell cultural
response of polycaprolactone scaffolds designed and
fabricated via fused deposition modeling. J Biomed Mat
Res 55: 203-216.
Imberti B, Seliktar D, Nerem RM, Remuzzi A (2002)
The response of endothelial cells to fluid shear stress using
a co-culture model of the arterial wall. Endothelium: J
Endoth Cell Res 9: 11-23.
Imegwu OJ, Entersz I, Graham AM, Nackman GB
(2001) Heterotypic smooth muscle cell/endothelial cell
interactions differ between species. J Surg Res 98: 85-88.
Jackson CJ, Nguyen M (1997) Human microvascular
endothelial cells differ from macrovascular endothelial
cells in their expression of matrix metalloproteinases. Int
J Biochem Cell B 29: 1167-1177.
Jain RK, Schlenger K, Hockel M, Yuan F (1997)
Quantitative angiogenesis assays: progress and problems.
Nature Med 3: 1203-1208.
Jeong SI, Kwon JH, Lim JI, Cho SW, Jung Y, Sung
WJ, Kim SH, Kim YH, Lee YM, Kim BS, Choi CY, Kim
SJ (2005) Mechano-active tissue engineering of vascular
smooth muscle using pulsatile perfusion bioreactors and
elastic PLCL scaffolds. Biomaterials 26: 1405-1411.
Jones EAV, le Noble F, Eichmann A (2006) What
Determines Blood Vessel Structure? Genetic
Prespecification vs. Hemodynamics. Physiology 21: 388-
395.
Kaigler D, Krebsbach PH, Polverini PJ, Mooney DJ
(2003) Role of vascular endothelial growth factor in bone
marrow stromal cell modulation of endothelial cells. Tissue
Eng 9: 95-103.
Kaigler D, Krebsbach PH, Wang Z, West ER, Horger
K, Mooney DJ (2006a) Transplanted endothelial cells
enhance orthotopic bone regeneration. J Dent Res 85: 633-
637.
Kaigler D, Wang Z, Horger K, Mooney DJ, Krebsbach
PH (2006b) VEGF scaffolds enhance angiogenesis and
bone regeneration in irradiated osseous defects. J Bone
Miner Res 21: 735-744.
Kaihara S, Borenstein J, Koka R, Lalan S, Ochoa ER,
Ravens M, Pien H, Cunningham B, Vacanti JP (2000)
Silicon micromachining to tissue engineer branched
vascular channels for liver fabrication. Tissue Eng 6: 105-
117.
Kane RS, Takayama S, Ostuni E, Ingber DE,
Whitesides GM (1999) Patterning proteins and cells using
soft lithography. Biomaterials 20: 2363-2376.
Kannan RY, Salacinski HJ, Sales K, Butler P, Seifalian
AM (2005) The roles of tissue engineering and
15
HCH Ko et al.                                                                                                                         Vascularisation when engineering thick tissues
vascularisation in the development of micro-vascular
networks: a review. Biomaterials 26: 1857-1875.
Karasek MA (1989) Microvascular endothelial cell
culture. J. Invest Dermatol 93: 33S-38S.
Kelm J M, Djonov V, Hoerstrup SP, Guenter CI, Ittner
LM, Greve F, Hierlemann A, Sanchez-Bustamante CD,
Perriard JC, Ehler E, Fussenegger M (2006a) Tissue-
transplant fusion and vascularization of myocardial
microtissues and macrotissues implanted into chicken
embryos and rats. Tissue Eng 12: 2541-2553.
Kelm JM, Djonov V, Ittner LM, Fluri D, Born W,
Hoerstrup SP, Fussenegger M (2006b) Design of custom-
shaped vascularized tissues using microtissue spheroids
as minimal building units. Tissue Eng 12: 2151-2160.
Kim BS, Putnam AJ, Kulik TJ, Mooney DJ (1998a)
Optimizing seeding and culture methods to engineer
smooth muscle tissue on biodegradable polymer matrices.
Biotechnol Bioeng 57: 46-54.
Kim SS, Utsunomiya H, Koski JA, Wu BM, Cima MJ,
Sohn J, Mukai K, Griffith LG, Vacanti JP (1998b) Survival
and function of hepatocytes on a novel three-dimensional
synthetic biodegradable polymer scaffold with an intrinsic
network of channels. Ann Surgery 228: 8-13.
Kinnaird T, Stabile E, Burnett MS, Epstein SE (2004)
Bone-marrow-derived cells for enhancing collateral
development: mechanisms, animal data, and initial clinical
experiences. Circ Res 95: 354-363.
Kleinman HK, Rorbach DH, Terranova VP, Varner HH,
Hewitt AT, Grotenddorst CM, Wilkes CM, Martin GR,
Seppa H, Schiffmann E (1982) Collagenous matrices as
determinants of cell function. In: Immunochemistry of the
Extracellular Matrix (Futhmayer H, ed). CRC Press Inc,
Boca Raton, FL pp 151-173
Koike N, Fukumura D, Gralla O, Au P, Schechner JS,
Jain RK (2004) Tissue engineering: creation of long-lasting
blood vessels. Nature 428: 138-139.
Kowalski J, Kwan HH, Prionas SD, Allison AC,
Fajardo LF (1992) Characterization and applications of
the disc angiogenesis system. Exp Mol Path 56: 1-19.
Kruyt MC, Dhert WJA, Oner FC, van Blitterswijk CA,
Verbout AJ, de Bruijn JD (2007) Analysis of ectopic and
orthotopic bone formation in cell-based tissue-engineered
constructs in goats. Biomaterials 28: 1798-1805.
Kuzuya M, Kinsella JL (1994) Induction of endothelial
cell differentiation in vitro by fibroblast-derived soluble
factors. Exp Cell Res 215: 310-318.
Laing AJ, Dillon JP, Condon ET, Coffey JC, Street JT,
Wang JH, McGuinness AJ, Redmond HP (2007a) A
systemic provascular response in bone marrow to
musculoskeletal trauma in mice. J Bone Joint Surg Br 89:
116-120.
Laing AJ, Dillon JP, Condon ET, Street JT, Wang JH,
McGuinness AJ, Redmond HP (2007b) Mobilization of
endothelial precursor cells: systemic vascular response to
musculoskeletal trauma. J Orthop Res 25: 44-50.
Lanza V, Ambrosi D, Preziosi L (2006) Exogenous
control of vascular network formation in vitro: A
mathematical model. Networks Heterogen Media 1: 621-
637.
Leclerc E, Furukawa KS, Miyata F, Sakai Y, Ushida T,
Fujii T (2004a) Fabrication of microstructures in
photosensitive biodegradable polymers for tissue
engineering applications. Biomaterials 25: 4683-4690.
Leclerc E, Sakai Y, Fujii T (2004b) Perfusion culture
of fetal human hepatocytes in microfluidic environments.
Biochem Eng J 20: 143-148.
Leclerc E, Sakai Y, Fujii T (2004c) Microfluidic PDMS
(polydimethylsiloxane) bioreactor for large-scale culture
of hepatocytes. Biotechnol Progr 20: 750-755.
Lee J, Schmid-Schonbein GW (1995) Biomechanics
of skeletal muscle capillaries: hemodynamic resistance,
endothelial distensibility, and pseudopod formation. Ann
Biomed Eng 23: 226-246.
Lee PC, Kibbe MR, Schuchert MJ, Stolz DB, Watkins
SC, Griffith BP, Billiar TR, Shears LL (2000) Nitric oxide
induces angiogenesis and upregulates alpha(v)beta(3)
integrin expression on endothelial cells. Microvasc Rese
60: 269-280.
Li S-T (2003) Biologic biomaterials: tissue-derived
biomaterials (collagen). In: Biomaterials: Principles and
Applications (Park JB, Bronzino JD, eds), CRC Press,
Boca Raton, FL, pp 117-139.
Li TS, Hamano K, Nishida M, Hayashi M, Ito H,
Mikamo A, Matsuzaki M (2003) CD117+ stem cells play
a key role in therapeutic angiogenesis induced by bone
marrow cell implantation. Am J Physiol 285: H931-937.
Li Y, Ma T, Kniss DA, Lasky LC, Yang ST (2001)
Effects of filtration seeding on cell density, spatial
distribution, and proliferation in nonwoven fibrous
matrices. Biotechnol Prog 17: 935-944.
Liu J, Wang XB, Park DS, Lisanti MP (2002) Caveolin-
1 expression enhances endothelial capillary tubule
formation. J Biol Chem 277: 10661-10668.
Lokmic Z, Stillaert F, Morrison WA, Thompson EW,
Mitchell GM (2007) An arteriovenous loop in a protected
space generates a permanent, highly vascular, tissue-
engineered construct. FASEB J 21: 511-522.
Long MW (2000) Tissue microenvironments. In: The
Biomedical Engineering Handbook, 2nd ed . CRC Press,
Boca Raton, FL 2: 1692-1709.
Ma PX, Choi JW (2001) Biodegradable polymer
scaffolds with well-defined interconnected spherical pore
network. Tissue Eng 7: 23-33.
MacLeod TM, Williams G, Sanders R, Green CJ (2003)
Prefabricated skin flaps in a rat model based on a dermal
replacement matrix Permacol. Br J Plast Surg 56: 775-
783.
Markowicz M, Koellensperger E, Neuss S,
Koenigschulte S, Bindler C, Pallua N (2006) Human bone
marrow mesenchymal stem cells seeded on modified
collagen improved dermal regeneration in vivo. Cell
Transplant 15: 723-732.
Mastrogiacomo M, Scaglione S, Martinetti R, Dolcini
L, Beltrame F, Cancedda R, Quarto R (2006) Role of
scaffold internal structure on in vivo bone formation in
macroporous calcium phosphate bioceramics. Biomaterials
27: 3230-3237.
Martin I, Wendt D, Heberer M (2004) The role of
bioreactors in tissue engineering. Trends Biotechnol 22:
80-86.
McCulloch AD, Harris AB, Sarraf CE, Eastwood M
(2004) New multi-cue bioreactor for tissue engineering of
16
HCH Ko et al.                                                                                                                         Vascularisation when engineering thick tissues
tubular cardiovascular samples under physiological
conditions. Tissue Eng 10: 565-573.
Meade-Tollin LC, Van Noorden CJ (2000) Time lapse
phase contrast video microscopy of directed migration of
human microvascular endothelial cells on matrigel. Acta
Histochem 102: 299-307.
Mikos AG, Herring SW, Ochareon P, Elisseeff J, Lu
HH, Kandel R, Schoen FJ, Toner M, Mooney D, Atala A,
Van Dyke ME, Kaplan D, Vunjak-Novakovic G (2006)
Engineering complex tissues. Tissue Eng 12: 3307-3339.
Mikos AG, Temenoff JS (2000) Formation of highly
porous biodegradable scaffolds for tissue engineering.
Electron J Biotechnol 3: 114-119.
Mironov V, Kasyanov V, McAllister K, Oliver S,
Sistino J, Markwald R (2003) Perfusion bioreactor for
vascular tissue engineering with capacities for longitudinal
stretch. J Craniofacial Surg 14: 340-347.
Moldovan NI, Ferrari M (2002) Prospects for
microtechnology and nanotechnology in bioengineering
of replacement microvessels. Arch Pathol LabMed 126:
320-324.
Murphy WL, Dennis RG, Kileny JL, Mooney DJ (2002)
Salt fusion: an approach to improve pore interconnectivity
within tissue engineering scaffolds. Tissue Eng 8: 43-52.
Nasseri BA, Pomerantseva I, Kaazempur-Mofrad MR,
Sutherland FW, Perry T, Ochoa E, Thompson CA, Mayer
JE, Jr., Oesterle SN, Vacanti JP (2003) Dynamic rotational
seeding and cell culture system for vascular tube formation.
Tissue Eng 9: 291-299.
Nerem RM, Alexander RW, Chappell DC, Medford
RM, Varner SE, Taylor WR (1998) The study of the
influence of flow on vascular endothelial biology. Am J
Med Sci 316: 169-175.
Neumann T, Nicholson BS, Sanders JE (2003) Tissue
engineering of perfused microvessels. Microvasc Res 66:
59-67.
Nguyen LL, D’Amore PA (2001) Cellular interactions
in vascular growth and differentiation. Int Rev Cytol 204:
1-48.
Nguyen M, Arkell J, Jackson CJ (2001) Human
endothelial gelatinases and angiogenesis. Int J Biochem
Cell Biol 33: 960-970.
Nicosia RF, Villaschi S (1995) Rat aortic smooth-
muscle cells become pericyte-like cells during
angiogenesis in-vitro. FASEB J 9: A587.
Niklason LE, Seruya M (2002) Small-diameter
vascular grafts. In: Methods in Tissue Engineering (Atala
A, Lanza R, eds) Academic Press, New York. pp 905-912.
Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S,
Marini R, Langer R (1999) Functional arteries grown in
vitro. Science 284: 489-493.
Niklason LE, Abbott W, Gao J, Klagges B, Hirschi KK,
Ulubayram K, Conroy N, Jones R, Vasanawala A, Sanzgiri
S, Langer R (2001) Morphologic and mechanical
characteristics of engineered bovine arteries. J Vasc Surg
33: 628-638.
Nillesen ST, Geutjes PJ, Wismans R, Schalkwijk J,
Daamen WF, van Kuppevelt TH (2007) Increased
angiogenesis and blood vessel maturation in acellular
collagen-heparin scaffolds containing both FGF2 and
VEGF. Biomaterials 28: 1123-1131.
Nomi M, Atala A, Coppi PD, Soker S (2002) Principals
of neovascularization for tissue engineering. Mol Aspects
Med 23: 463-483.
Nor JE, Peters MC, Christensen JB, Sutorik MM, Linn
S, Khan MK, Addison CL, Mooney DJ, Polverini PJ (2001)
Engineering and characterization of functional human
microvessels in immunodeficient mice. Lab Invest 81: 453-
463.
Norrby K (1997) Angiogenesis: new aspects relating
to its initiation and control. APMIS 105: 417-437.
Norrby K (2006) In vivo models of angiogenesis. J Cell
Mol Med 10: 588-612.
Okano T, Matsuda T (1998) Muscular tissue
engineering: capillary-incorporated hybrid muscular
tissues in vivo tissue culture. Cell Transplant7: 435-442.
Otani A, Kinder K, Ewalt K, Otero FJ, Schimmel P,
Friedlander M (2002) Bone marrow-derived stem cells
target retinal astrocytes and can promote or inhibit retinal
angiogenesis. Nature Med 8: 1004-1010.
Park H, Temenoff JS, Tabata Y, Caplan AI, Mikos AG
(2007) Injectable biodegradable hydrogel composites for
rabbit marrow mesenchymal stem cell and growth factor
delivery for cartilage tissue engineering. Biomaterials 28:
3217-3227.
Patan S, Munn LL, Tanda, S, Roberge S, Jain RK, Jones
RC (2001) Vascular morphogenesis and remodeling in a
model of tissue repair – blood vessel formation and growth
in the ovarian pedicle after ovariectomy. Circ Res 89: 723-
731.
Perea H, Aigner J, Hopfner U, Wintermantel E (2006)
Direct magnetic tubular cell seeding: a novel approach for
vascular tissue engineering. Cells Tissues Organs 183: 156-
165.
Pieper JS, Hafmans T, van Wachem PB, van Luyn
MJA, Brouwer LA, Veerkamp JH, van Kuppevelt TH
(2002) Loading of collagen-heparan sulfate matrices with
bFGF promotes angiogenesis and tissue generation in rats.
J Biomed Mat Res 62: 185-194.
Polykandriotis E, Arkudas A, Euler S, Beier JP, Horch
RE, Kneser U (2006) Prevascularisation strategies in tissue
engineering. Handchir Mikrochir Plast Chir 38: 217-223.
Polykandriotis E, Arkudas A, Horch RE, Sturzl M,
Kneser U (2007) Autonomously vascularized cellular
constructs in tissue engineering: opening a new perspective
for biomedical science. J Cell Mol Med 11: 6-20.
Pries AR, Secomb TW (2002) Structural adaptation of
microvascular networks and development of hyptertension.
Microcirculation 9: 305-314.
Radisic M, Euloth M, Yang L, Langer R, Freed LE,
Vunjak-Novakovic G (2003) High-density seeding of
myocyte cells for cardiac tissue engineering. Biotechnol
Bioeng 82: 403-414.
Radisic M, Park H, Chen F, Salazar-Lazzaro JE, Wang
Y, Dennis R, Langer R, Freed LE, Vunjak-Novakovic G
(2006) Biomimetic approach to cardiac tissue engineering:
oxygen carriers and channeled scaffolds. Tissue Eng 12:
2077-2091.
Rajantie I, Ilmonen M, Alminaite A, Ozerdem U,
Alitalo K, Salven P (2004) Adult bone marrow-derived
cells recruited during angiogenesis comprise precursors
17
HCH Ko et al.                                                                                                                         Vascularisation when engineering thick tissues
for periendothelial vascular mural cells. Blood 104: 2084
2086.
Reilly TM, Seldes R, Luchetti W, Brighton CT (1998)
Similarities in the phenotypic expression of pericytes and
bone cells. Clin Orthop Relat R 346: 95-103.
Rezai N, Podor TJ, McManus BM (2004) Bone marrow
cells in the repair and modulation of heart and blood
vessels: emerging opportunities in native and engineered
tissue and biomechanical materials. Artif Organs 28: 142-
151.
Richard L, Velasco P, Detmar M (1998) Isolation and
culture of microvascular endothelial cells.In: Methods in
Molecular Medicine Vol. 18: Tissue Engineering (Morgan
JR, Yarmush, M.L., eds) Humana Press Inc, Totowa NJ.
pp 261-269.
Sachlos E, Gotora D, Czernuszka JT (2006) Collagen
scaffolds reinforced with biomimetic composite nano-sized
carbonate-substituted hydroxyapatite crystals and shaped
by rapid prototyping to contain internal microchannels.
Tissue Eng 12: 2479-2487.
Sachlos E, Reis N, Ainsley C, Derby B, Czernuszka
JT (2003) Novel collagen scaffolds with predefined
internal morphology made by solid freeform fabrication.
Biomaterials 24: 1487-1497.
Schantz J-T, Lee CM, Hutmacher DW (2005) Design
of vascular channel networks in complex-shaped scaffolds
for bone regeneration. The 8th TESI Annual Meeting. p
127.
Schultheiss D, Gabouev AI, Cebotari S, Tudorache I,
Walles T, Schlote N, Wefer J, Kaufmann PM, Haverich A,
Jonas U, Stief CG, Mertsching H (2005) Biological
vascularized matrix for bladder tissue engineering: matrix
preparation, reseeding technique and short-term
implantation in a porcine model. J Urol 173: 276-280.
Seal BL, Otero TC, Panitch A (2001) Polymeric
biomaterials for tissue and organ regeneration. Mat Sci
Eng R 34: 147-230.
Secomb TW, Pries AR (2002) Information transfer in
microvascular networks. Microcirculation 9:377-187.
Seliktar D, Nerem RM (2002) Blood vessel substitute.
In: Methods in Tissue Engineering (Atala A, Lanza R, eds),
Academic Press, New York. pp 891-902.
Sengupta S, Toh SA, Sellers LA, Skepper JN, Koolwijk
P, Leung HW, Yeung HW, Wong RN, Sasisekharan R, Fan
TP (2004) Modulating angiogenesis: the yin and the yang
in ginseng. Circulation 110: 1219-1225.
Shen JY, Chan-Park MB, Feng ZQ, Chan V, Feng ZW
(2006a) UV-embossed microchannel in biocompatible
polymeric film: application to control of cell shape and
orientation of muscle cells. J Biomed Mater Res B Appl
Biomater 77: 423-430.
Shen JY, Chan-Park MB, He B, Zhu AP, Zhu X,
Beuerman RW, Yang EB, Chen W, Chan V (2006b) Three-
dimensional microchannels in biodegradable polymeric
films for control orientation and phenotype of vascular
smooth muscle cells. Tissue Eng 12: 2229-2240.
Sheridan MH, Shea LD, Peters MC, Mooney DJ (2000)
Bioabsorbable polymer scaffolds for tissue engineering
capable of sustained growth factor delivery. J Control
Release 64: 91-102.
Shin M, Matsuda K, Ishii O, Terai H, Kaazempur-
Mofrad M, Borenstein J, Detmar M, Vacanti JP (2004)
Endothelialized networks with a vascular geometry in
microfabricated poly(dimethyl siloxane). Biomed
Microdevices 6: 269-278.
Short B, Brouard N, Occhiodoro-Scott T,
Ramakrishnan A, Simmons PJ (2003) Mesenchymal stem
cells. Arch Med Res 34: 565-571.
Sieminski AL, Hebbel RP, Gooch KJ (2004) The
relative magnitudes of endothelial force generation and
matrix stiffness modulate capillary morphogenesis in vitro.
Exp Cell Res 297: 574-584.
Sieminski AL, Padera RF, Blunk T, gooch KJ (2002)
Systemic delivery of human growth hormone using
genetically modified tissue-engineered microvascular
networks: Prolonged delivery and endothelial survival with
inclusion of nonendothelial cells. Tissue Eng 8: 1057-1069.
Sims DE (2000) Diversity within pericytes. Clin Exp
Pharmacol P 27: 842-846.
Skalak R, Fox CF. (1988) Tissue engineering.
Proceedings of a workshop held at Granlibakken, Lake
Tahoe, California, February 26-29. pp 26-29.
Slaaf D, Tangelder GJ, Reneman R (1993) The physics
of heart and circulation. In: Physics of the Microcirculation.
Institute of Physics, Bristol. pp 383-416.
Sodian R, Lemke T, Fritsche C, Hoerstrup SP, Fu P,
Potapov EV, Hausmann H, Hetzer R (2002) Tissue-
engineering bioreactors: a new combined cell-seeding and
perfusion system for vascular tissue engineering. Tissue
Eng 8: 863-870.
Song J, Rolfe BE, Hayward IP, Campbell GR,
Campbell JH (2000) Effects of collagen gel configuration
on behavior of vascular smooth muscle cells in vitro:
Association with vascular morphogenesis. In Vitro Cell
Dev-An 36: 600-610.
Srouji S, Kizhner T, Livne E (2006) 3D scaffolds for
bone marrow stem cell support in bone repair. Regen Med
1: 519-528.
Stegemann JP, Nerem RM (2003a) Phenotype
modulation in vascular tissue engineering using
biochemical and mechanical stimulation. Ann Biomed Eng
31: 391-402.
Stegemann JP, Nerem RM (2003b) Altered response
of vascular smooth muscle cells to exogenous biochemical
stimulation in two- and three-dimensional culture. Exp Cell
Res 283: 146-155.
Steven FS (1976) Preparation of macromolecular
collagens. In: The Methodology of Connective Tissue
Research (Hall DA, ed). Joynson and Bruwers, Oxford,
UK. pp 19-27.
Sumpio BE, Riley JT, Dardik A (2002) Cells in focus:
endothelial cell. Int J Biochem Cell Biol 34: 1508-1512.
Sundback C, Hadlock T, Cheney M, Vacanti J (2003)
Manufacture of porous polymer nerve conduits by a novel
low-pressure injection molding process. Biomaterials 24:
819-830.
Tabata Y, Miyao M, Ozeki M, Ikada Y (2000)
Controlled release of vascular endothelial growth factor
by use of collagen hydrogels. J Biomat Sci-Polymer Ed
11: 915-930.
18
HCH Ko et al.                                                                                                                         Vascularisation when engineering thick tissues
Takahashi T, Kalka C, Masuda H, Chen D, Silver M,
Kearney M, Magner M, Isner JM, Asahara T (1999)
Ischemia- and cytokine-induced mobilization of bone
marrow-derived endothelial progenitor cells for
neovascularization. Nature Med 5: 434-438.
Tan BK, Chen HC, He TM, Song IC (2004) Flap
prefabrication – the bridge between conventional flaps and
tissue-engineered flaps. Ann Acad Med Singapore 33: 662-
666.
Tao H, Ma DD (2003) Evidence for transdifferentiation
of human bone marrow-derived stem cells: recent progress
and controversies. Pathology 35: 6-13.
Thomas WE (1999) Brain macrophages: on the role of
pericytes and perivascular cells. Brain Res Rev 31: 42-57.
Thomas AC, Campbell GR, Campbell JH (2003)
Advances in vascular tissue engineering. Cardiovasc
Pathol 12: 271-276.
Thomas JB, Milner JS, Steinman DA (2002) On the
influence of vessel planarity on local hemodynamics at
the human carotid bifurcation. Biorheology 39: 443-448.
Thomas L (2006) Stem-cell factor induces angiogenesis
in vivo. Lancet Neurol 5: 474.
Tonello C, Zavan B, Cortivo R, Brun P, Panfilo S,
Abatangelo G (2003) In vitro reconstruction of human
dermal equivalent enriched with endothelial cells.
Biomaterials 24: 1205-1211.
Unger RE, Krump-Konvalinkova V, Peters K,
Kirkpatrick CJ (2002) In vitro expression of the endothelial
phenotype: comparative study of primary isolated cells and
cell lines, including the novel cell line HPMEC-ST1.6R.
Microvasc Res. 64: 384-397.
Vacanti JP, Borenstein J, Pien H, Cunningham B (2003)
Fabrication of vascularized tissue using microfabricated
two-dimensional molds. United States Patent Application
Publication. US 20030003575A1 C12N 005/08; C12M
001/14; C12M 003/04 18.
Vailhe B, Vittet D, Feige JJ (2001) In vitro models of
vasculogenesis and angiogenesis. Lab Invest 81: 439-452.
Vallien G, Langley R, Jennings S, Specian R, Granger
DN (2000) Expression of endothelial cell adhesion
molecules in neovascularized tissue. Microcirculation 7:
249-258.
van den Dolder J, Bancroft GN, Sikavitsas VI, Spauwen
PH, Jansen JA, Mikos AG (2003) Flow perfusion culture
of marrow stromal osteoblasts in titanium fiber mesh. J
Biomed Mat Res A 64: 235-241.
Vernon RB, Lara SL, Drake CJ, Iruelaarispe ML,
Angello JC, Little CD, Wight TN, Sage EH (1995)
Organized type-I collagen influences endothelial patterns
during spontaneous angiogenesis in-vitro – planar cultures
as models of vascular development. In Vitro Cell Dev-An
31: 120-131.
Vozzi G, Previti A, Ciaravella G, Ahluwalia A (2004)
Microfabricated fractal branching networks. J Biomed Mat
Res A 71: 326-333.
Wendt D, Marsano A, Jakob M, Heberer M, Martin I
(2003) Oscillating perfusion of cell suspensions through
three-dimensional scaffolds enhances cell seeding
efficiency and uniformity. Biotechnol Bioeng 84: 205-214.
Wintermantel E, Mayer J, Blum J, Eckert KL, Luscher
P, Mathey M (1996) Tissue engineering scaffolds using
superstructures. Biomaterials 17: 83-91.
Wu X, Rabkin-Aikawa E, Guleserian KJ, Perry TE,
Masuda Y, Sutherland FW, Schoen FJ, Mayer Jr JE,
Bischoff J (2004) Tissue-engineered microvessels on three-
dimensional biodegradable scaffolds using human
endothelial progenitor cells. Am J Physiol-Heart C 287:
H480-487.
Yang TH, Miyoshi H, Ohshima N (2001) Novel cell
immobilization method utilizing centrifugal force to
achieve high-density hepatocyte culture in porous scaffold.
J Biomed Mat Res 55: 379-386.
Zantop T, Gilbert TW, Yoder MC, Badylak SF (2006)
Extracellular matrix scaffolds are repopulated by bone
marrow-derived cells in a mouse model of achilles tendon
reconstruction. J Orthop Res 24: 1299-1309.
Zhao X, Kalliomaki S, Wang X, Kalliomaki J,
Andersson R (2005) Angiogenesis, endothelial cell
functions, and tumor cell growth in biodegradable and
nonbiodegradable devices. J Biomed Mater Res B Appl
Biomater 74: 774-781.
Zhou YF, Chen FL, Ho ST, Woodruff MA, Lim TM,
Hutmacher DW (2007) Combined marrow stromal cell-
sheet techniques and high-strength biodegradable
composite scaffolds for engineered functional bone grafts.
Biomaterials 28: 814-824.
Zeigelhoeffer T, Fernandez B, Kostin S, Heil M,
Voswinckel R, Helisch A, Schaper W (2004) Bone marrow-
derived cells do not incorporate into the adult growing
vasculature. Circ Res 94: 230-238.
Zein I, Hutmacher DW, Tan KC, Teoh SH (2002) Fused
deposition modeling of novel scaffold architectures for
tissue engineering applications. Biomaterials 23: 1169-
1185.
Ziegler T, Alexander RW, Nerem RM (1995) An
endothelial cell-smooth muscle cell co-culture model for
use in the investigation of flow effects on vascular biology.
Ann Biomed Eng 23: 216-225.
Discussion with Reviewers
V. Braunstein: The authors mention rightly, that there
seems to be a small range between desirable and
undesirable ischaemia in engineered tissues leading to the
stimulation of vessel ingrowth. Which systemic or local
parameters could be helpful to have a more or less
continuous monitoring of the viability of the engineered
tissues?
Authors: At the moment, there seems to be no one optimal
combination of cells, matrix or scaffold design for
controlling vessel ingrowth and viability in vitro. Scaffold
architecture parameters, such as porosity, pore size
distribution, degree of pore interconnectivity, and scaffold
pore system tortuosity, all influence the capacity for cell
viability and nutrient medium mass transfer into a scaffold.
We routinely monitor pH, glucose, lactate and cell viability
using metabolic assays such as AlamarBlue. Using these
‘aggregate’ measures, and by controlling the architectural
and culturing environment parameters, we aim to influence
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formation of, for example, ischaemic gradients within the
three-dimensional construct. Recent advances in imaging
technology and fluorescent probes are also bringing the
spatial visualisation of such phenomena closer to reality.
Ultimately we would like to utilise these approaches to
dynamically influence vessel ingrowth through, for
example, temporal changes in nutrient medium
composition, changing the magnitude of fluid flow within
the tissue analogue, or altering the amount of dissolved
oxygen in the medium. If we can quantify and correlate
distinct physical growth conditions with the resulting
effects on tissue growth, we may be on our way to defining
the exact combination of parameters that can control vessel
ingrowth in vitro.
L. Koole: Obviously, it is technically difficult to realise
formation of arterial and venous blood vessels in vitro.
Will there be perfusion? If so, with what? If not: will the
tissues be capable of withstanding arterial pressure after
implantation?
Authors: This system is designed to eventually be perfused
through the nutrient channels. The extensive literature in
this area indicates that perfusion is beneficial for proper
“tissue” formation and cell alignment, with biomimetic
pulsatile perfusion conferring enhanced mechanical
properties on engineered blood vessels. The perfusion
pressure implemented in vitro will depend on the type of
tissue being created, since the distribution of pressure along
the vascular tree strongly depends on the type of organ
and its vascular topology. The compliance and elastic
modulus of the supporting scaffold are important
parameters here, but we have not investigated these at this
early stage. Since we are essentially aiming to create a
vascularized ‘block’ of tissue, we have a greater mass of
scaffolding material available than would be the case for
an engineered vascular graft for example, and this may
offer some advantages in terms of more bulk material
strength. To date we have cultured these constructs with
normal cell culture medium such as MCDB-131 with
growth supplements, but recognise that this needs to be
optimised to take into consideration the changing needs
of the growing tissue. A crucial stage will be the
performance of the constructs when perfused with whole
blood in vitro, since it is clearly essential to avoid thrombus
formation when implanted.
L. Koole: How do the authors look upon the endothelium,
i.e. the cells that will form the interface between the flowing
blood and the implant? Will there be a difference in arterial
endothelium and venous endothelium prior to implantation,
or differentiation only after implantation?
Authors: A functional endothelium is critical to the success
of this approach for many reasons, not the least of which
is the presentation of a non-thrombogenic surface to the
flowing blood. We have seeded the constructs with
microvascular endothelial cells both alone and co-cultured
with other cell types. However, achieving spatial
localisation to represent venous and arterial elements
would be technically challenging. From a biomimetic
standpoint, clearly fluid flow forces have a part in
determining where arterial and venous endothelium start
and end in the vasculature. If we can expose the tissue
analogue to an appropriate gradient of force we may be
able to form such a differentiated system in vitro before
implantation. Whilst blood plasma is a Newtonian fluid,
whole blood exhibits shear-thinning behaviour (i.e.
viscosity decreases when shear rate increases) due
primarily to red blood cell aggregation. It may therefore
be necessary to use cell culture medium containing
particles that mimic red blood cells, or use whole blood.
That said we believe that it may be unwise and unnecessary
to ‘overengineer’ the process of vascularisation. Rather,
we aim to provide a template which can then be remodelled
and adapted by the host tissues whilst maintaining
functionality.
L. Koole: Do the authors have any information on the
suturability of engineered tissues? In other words: can
engineered tissue be “connected” to the arterial and venous
vessels of the recipient organism, using standard
anastomosis techniques? Is there really no risk that the
(new or existing) blood vessels will tear at the suture site,
or burst altogether?
Authors: Part of our original research aim was to create
suturable vascularised tissue analogues. Whilst the porous
PLGA materials used for the bulk scaffold clearly lack
appropriate mechanical properties, our approach will be
to incorporate suturable nanofibrous polyurethane mesh
tubes at the anastomoses. As well as having mechanical
properties designed to minimise undesirable outcomes such
as anastomotic hyperplasia, these materials would degrade
slowly or not at all, giving extra strength for suturing and
time for host cell infiltration to reinforce the anastomosis.
It may also be possible to seed this region with a high
proportion of vascular smooth muscle cells to give more
strength to the vessel during suturing.
